International Assets Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Buy |
+45,714
| New | +$33.4K | ﹤0.01% | 831 |
|
|
2025
Q1 | – | Sell |
-45,606
| Closed | -$63.8K | – | 785 |
|
|
2024
Q4 | $63.8K | Sell |
45,606
-1,993
| -4% | -$2.79K | 0.01% | 798 |
|
|
2024
Q3 | $45.8K | Buy |
47,599
+5,381
| +13% | +$5.17K | 0.13% | 160 |
|
|
2024
Q2 | $73K | Buy |
42,218
+500
| +1% | +$865 | 0.01% | 1045 |
|
|
2024
Q1 | $100K | Sell |
41,718
-1,072
| -3% | -$2.57K | 0.01% | 731 |
|
|
2023
Q4 | $142K | Buy |
42,790
+29,014
| +211% | +$96.6K | 0.02% | 660 |
|
|
2023
Q3 | $54.7K | Buy |
+13,776
| New | +$54.7K | 0.01% | 587 |
|